Drug · DIN 02223929
VAXIGRIP
5 ML MULTIDOSE VIAL
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since July 18, 2019; first marketed October 17, 1997.
- Drug Identification Number (DIN)
- 02223929
- Company (DIN owner)
- Sanofi Vaccines Canada Ltd.Toronto, Ontario, Canada
- Schedule
- Schedule D
- Dosage form
- Suspension
- Route
- Intramuscular
- Therapeutic class (ATC)
- Influenza, inactivated, split virus or surface antigen J07BB02
- Class
- Human
- Record last updated
- August 6, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| HAEMAGGLUTININ-STRAIN A (H1N1) | 15 MCG | 0.5 ML |
| HAEMAGGLUTININ-STRAIN A (H3N2) | 15 MCG | 0.5 ML |
| HAEMAGGLUTININ-STRAIN B | 15 MCG | 0.5 ML |
Other DINs named VAXIGRIP
- DIN 02367718 · Cancelled Post Market